2011•Zhongguo jiceng yiyaoRequires access

Controlled observation of ieflunomide and cyclophosphamide on lupus nephritis

Xiao-ling Yuan, Zhaojun Guo, Jia-chang Liu, Fanglin Lu, Chen Hai-geng

Open publisher page 0 citations

Abstract

Objective To compare the therapeutic effect, adverse effects and safety of leflunomide (LEF)and cyclophosphamide(CTX) on lupus nephritis(LN). Methods 43 patients with reactive LN were randomly divided into two groups. Based on hormone application,22 cases in LEF group were given LEF orally and 21 cases in CTX group were given CTX intravenous drip discontinuously. They were followed up for six months. The related indexes and possible concomitant adverse effects were detected. Results The total effective rate in LEF group was 81.8% and that in CTX group was 85.7%. The tolerance in LEF group was better and 3 cases had adverse effects. 13 cases in CTX group had adverse effects. Conclusion LEF had the same efficacy as CTX in the LN therapy, but the tolerance is better and the side effects are minor than CTX. Key words: Leflunomide;  Cyclophosphamide ;  Lupus nephritis

About this research paper

What this paper is about

Objective To compare the therapeutic effect, adverse effects and safety of leflunomide (LEF)and cyclophosphamide(CTX) on lupus nephritis(LN). Methods 43 patients with reactive LN were randomly divided into two groups. Based on hormone application,22 cases in LEF group were given LEF orally and 21 cases in CTX group were given CTX intravenous drip discontinuously. They were followed up for six months. The related indexes and possible concomitant adverse effects were detected. Results The total effective rate in LEF group was 81.8% and that in CTX group was 85.7%. The tolerance in LEF group was better and 3 cases had adverse effects. 13 cases in CTX group had adverse effects. Conclusion LEF had the same efficacy as CTX in the LN therapy, but the tolerance is better and the side effects are minor than CTX. Key words: Leflunomide;  Cyclophosphamide ;  Lupus nephritis

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare the therapeutic effect, adverse effects and safety of leflunomide (LEF)and cyclophosphamide(CTX) on lupus nephritis(LN). Methods 43 patients with reactive LN were randomly divided into two groups. Based on hormone application,22 cases in LEF group were given LEF orally and 21 cases in CTX group were given CTX intravenous drip discontinuously. They were followed up for six months. The related indexes and possible concomitant adverse effects were detected. Results The total effective rate in LEF group was 81.8% and that in CTX group was 85.7%. The tolerance in LEF group was better and 3 cases had adverse effects. 13 cases in CTX group had adverse effects. Conclusion LEF had the same efficacy as CTX in the LN therapy, but the tolerance is better and the side effects are minor than CTX. Key words: Leflunomide;  Cyclophosphamide ;  Lupus nephritis

Key concepts: Medicine, Cyclophosphamide, Lupus nephritis, Adverse effect, Leflunomide, Concomitant, Internal medicine, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Controlled observation of ieflunomide and cyclophosphamide on lupus nephritis — Research Paper | ScholarLens